Fundraising FoxChanRx
Cleveland, US · Delaware corporation · 3 known investors
Find your way into ChanRx
Sign up to see every warm intro you have to ChanRx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ChanRx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AB
Arthur BrownFounder
HD
Howard DittrichExecutive
RB
Robert Baltera, Jr.Executive
RK
Rajesh KhoslaExecutive
Board
KL
JD
Jerel DavisBoard director
JT
JG
Jim GrahamBoard director
Investors · 3
Frazier Life SciencesinferredPalo Altovia James N. Topper · board
How we know: board seat on SEC Form D · Not right? Tell us
Jumpstart VenturesreportedCleveland · $500K – $2M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 3 rounds · 2011–2015
▶$4.5MraisedJul 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedJul 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin LalandeDirector
- James TopperDirector
- Robert Baltera, Jr.Executive Officer, Director
- Brian FarmerExecutive Officer
- Jerel DavisDirector
- Howard DittrichExecutive Officer
- Offering amount
- $4.7M
- Amount sold
- $4.5M
- First sale
- Nov 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.6MraisedFeb 2015 · 18 investors · PharmaceuticalsRule 506(b)
▶$16.6MraisedFeb 2015 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin LalandeDirector
- Howard DittrichExecutive Officer
- Robert Baltera, Jr.Executive Officer, Director
- Jerel DavisDirector
- James TopperDirector
- Offering amount
- $31.9M
- Amount sold
- $16.6M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJun 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$1MraisedJun 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rajesh KhoslaExecutive Officer, Director
- Jim GrahamDirector
- Kevin LalandeDirector
- Arthur BrownExecutive Officer, Director
- Howard DittrichExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $3.5K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded ChanRx?
- ChanRx was founded by Arthur Brown.
- Who are ChanRx's investors?
- ChanRx's investors include Frazier Life Sciences, Jumpstart Ventures, Sante Health Ventures.
- How much funding has ChanRx raised?
- ChanRx has disclosed $22.1M raised across 3 rounds.
- Where is ChanRx headquartered?
- ChanRx is headquartered in Cleveland, US.